Kolexia
Bahadoran Philippe
Dermatologie
Hôpital De l'Archet
Nice, France
208 Activités
7.9 K Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Mélanome Tumeurs cutanées Vitiligo Mélanome de Dubreuilh Mélanose Carcinomes Métastase tumorale Carcinome basocellulaire Lentigo

Industries

Pierre Fabre
7 collaboration(s)
Dernière en 2022
Almirall
5 collaboration(s)
Dernière en 2023
B3TSI
4 collaboration(s)
Dernière en 2020
UCB
3 collaboration(s)
Dernière en 2023

Dernières activités

Tirbaso: Open, Prospective Study Evaluating the Efficacy and Safety of 0.05% Tirbanubulin (Klisiry®) in the Treatment of Basal Cell Carcinoma
Essai Clinique (CHU Nice)   15 mars 2024
Real-life practice of reflectance confocal microscopy in France: A prospective multicenter study.
Journal of the American Academy of Dermatology   20 février 2024
Hypnosis for Chronic Idiopathic Pruritus: A Prospective Study of Hypnosis for Chronic Idiopathic Pruritus
Essai Clinique (CHU Nice)   11 janvier 2024
Un nouveau signe de photovieillissement en microscopie confocale : l’élastose nodulaire
Journées dermatologiques de Paris 2023   01 décembre 2023
362P CYBERNEO trial: Update of results at 14 years of follow-up
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
melatrans: Single-cell Transcriptome Identification of UV- and Visible-light-induced Genes in Human Melanocytes in Vivo
Essai Clinique (CHU Nice)   05 septembre 2023
Reliability and agreement testing of a new automated measurement method to determine extent of facial vitiligo using standardized UV images and a dedicated algorithm.
The British journal of dermatology   24 août 2023
PICABAS: Open, Prospective, Single-center Study Evaluating the Efficacy and Safety of 0.05% Ingenol Mebutate (Picato® 500) in the Treatment of Basal Cell Carcinoma
Essai Clinique (CHU Nice)   20 juillet 2023
MelBase: Constitution of a National Cohort of Patients With Metastatic Melanoma Resectable Stage II or Stage III or IV or Unresectable Primary With the Objective of Setting up Epidemiological Monitoring and Clinico-biological Database, MELBASE
Essai Clinique (Assistance publique – Hôpitaux de Paris)   07 juillet 2023
Role of ultra-high-frequency ultrasound in the diagnosis and management of basal cell carcinoma: pilot study based on 117 cases.
Clinical and experimental dermatology   01 mai 2023